Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Preparation and characterization of SARS in-house reference antiserum

Identifieur interne : 001277 ( Pmc/Checkpoint ); précédent : 001276; suivant : 001278

Preparation and characterization of SARS in-house reference antiserum

Auteurs : Jiansan Zhang [République populaire de Chine] ; Yuxuan Liu [République populaire de Chine] ; Liangxiang Hu [République populaire de Chine] ; Qiang Gao [République populaire de Chine] ; Zhenshan Zhang [République populaire de Chine] ; Xiaomei Zhang [République populaire de Chine] ; Jiangting Chen [République populaire de Chine] ; Xuejie Gong [République populaire de Chine] ; Lifei Song [République populaire de Chine] ; Yufen Liu [République populaire de Chine] ; Jing Li [République populaire de Chine] ; Shufen Li [République populaire de Chine] ; Jinfeng Huang [République populaire de Chine] ; Ye Ning [République populaire de Chine] ; Hong Gao [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Xiaoping Dong [République populaire de Chine] ; Jianguo Wei [République populaire de Chine] ; Guanmu Dong [République populaire de Chine] ; Weidong Yin [République populaire de Chine]

Source :

RBID : PMC:7115399

Abstract

A reference antiserum for SARS is in urgent need in the development of SARS vaccine and other serological test of SARS research. Convalescent serum was collected from clinical confirmed patient. ELISA, Western-blotting and neutralization assay detected specific antibody against SARS coronavirus. This antiserum was prepared as in-house reference antiserum, freeze-dried and sealed in ampoules. The potency of this reference antiserum is defined to be 52.7 U after extensive calibration. Further, collaborative studies for the evaluation of this serum are needed in order to satisfy the requirements for international reference antiserum.


Url:
DOI: 10.1016/j.vaccine.2004.12.032
PubMed: 16269206
PubMed Central: 7115399


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:7115399

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Preparation and characterization of SARS in-house reference antiserum</title>
<author>
<name sortKey="Zhang, Jiansan" sort="Zhang, Jiansan" uniqKey="Zhang J" first="Jiansan" last="Zhang">Jiansan Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Liu, Yuxuan" sort="Liu, Yuxuan" uniqKey="Liu Y" first="Yuxuan" last="Liu">Yuxuan Liu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hu, Liangxiang" sort="Hu, Liangxiang" uniqKey="Hu L" first="Liangxiang" last="Hu">Liangxiang Hu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gao, Qiang" sort="Gao, Qiang" uniqKey="Gao Q" first="Qiang" last="Gao">Qiang Gao</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Zhenshan" sort="Zhang, Zhenshan" uniqKey="Zhang Z" first="Zhenshan" last="Zhang">Zhenshan Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Xiaomei" sort="Zhang, Xiaomei" uniqKey="Zhang X" first="Xiaomei" last="Zhang">Xiaomei Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chen, Jiangting" sort="Chen, Jiangting" uniqKey="Chen J" first="Jiangting" last="Chen">Jiangting Chen</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gong, Xuejie" sort="Gong, Xuejie" uniqKey="Gong X" first="Xuejie" last="Gong">Xuejie Gong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Song, Lifei" sort="Song, Lifei" uniqKey="Song L" first="Lifei" last="Song">Lifei Song</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Liu, Yufen" sort="Liu, Yufen" uniqKey="Liu Y" first="Yufen" last="Liu">Yufen Liu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Li, Jing" sort="Li, Jing" uniqKey="Li J" first="Jing" last="Li">Jing Li</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Li, Shufen" sort="Li, Shufen" uniqKey="Li S" first="Shufen" last="Li">Shufen Li</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Huang, Jinfeng" sort="Huang, Jinfeng" uniqKey="Huang J" first="Jinfeng" last="Huang">Jinfeng Huang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ning, Ye" sort="Ning, Ye" uniqKey="Ning Y" first="Ye" last="Ning">Ye Ning</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gao, Hong" sort="Gao, Hong" uniqKey="Gao H" first="Hong" last="Gao">Hong Gao</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qin, Chuan" sort="Qin, Chuan" uniqKey="Qin C" first="Chuan" last="Qin">Chuan Qin</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">The Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dong, Xiaoping" sort="Dong, Xiaoping" uniqKey="Dong X" first="Xiaoping" last="Dong">Xiaoping Dong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Institute for Virology, Chinese Center for Disease Control and Prevention, Beijing 100052, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute for Virology, Chinese Center for Disease Control and Prevention, Beijing 100052</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wei, Jianguo" sort="Wei, Jianguo" uniqKey="Wei J" first="Jianguo" last="Wei">Jianguo Wei</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dong, Guanmu" sort="Dong, Guanmu" uniqKey="Dong G" first="Guanmu" last="Dong">Guanmu Dong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff4">National Institute for the Control of Pharmaceutical and Biological Products, Tiantan Xili 2, Beijing 100050, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Institute for the Control of Pharmaceutical and Biological Products, Tiantan Xili 2, Beijing 100050</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yin, Weidong" sort="Yin, Weidong" uniqKey="Yin W" first="Weidong" last="Yin">Weidong Yin</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">16269206</idno>
<idno type="pmc">7115399</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115399</idno>
<idno type="RBID">PMC:7115399</idno>
<idno type="doi">10.1016/j.vaccine.2004.12.032</idno>
<date when="2005">2005</date>
<idno type="wicri:Area/Pmc/Corpus">001527</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001527</idno>
<idno type="wicri:Area/Pmc/Curation">001527</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001527</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001277</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001277</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Preparation and characterization of SARS in-house reference antiserum</title>
<author>
<name sortKey="Zhang, Jiansan" sort="Zhang, Jiansan" uniqKey="Zhang J" first="Jiansan" last="Zhang">Jiansan Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Liu, Yuxuan" sort="Liu, Yuxuan" uniqKey="Liu Y" first="Yuxuan" last="Liu">Yuxuan Liu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hu, Liangxiang" sort="Hu, Liangxiang" uniqKey="Hu L" first="Liangxiang" last="Hu">Liangxiang Hu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gao, Qiang" sort="Gao, Qiang" uniqKey="Gao Q" first="Qiang" last="Gao">Qiang Gao</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Zhenshan" sort="Zhang, Zhenshan" uniqKey="Zhang Z" first="Zhenshan" last="Zhang">Zhenshan Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Xiaomei" sort="Zhang, Xiaomei" uniqKey="Zhang X" first="Xiaomei" last="Zhang">Xiaomei Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chen, Jiangting" sort="Chen, Jiangting" uniqKey="Chen J" first="Jiangting" last="Chen">Jiangting Chen</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gong, Xuejie" sort="Gong, Xuejie" uniqKey="Gong X" first="Xuejie" last="Gong">Xuejie Gong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Song, Lifei" sort="Song, Lifei" uniqKey="Song L" first="Lifei" last="Song">Lifei Song</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Liu, Yufen" sort="Liu, Yufen" uniqKey="Liu Y" first="Yufen" last="Liu">Yufen Liu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Li, Jing" sort="Li, Jing" uniqKey="Li J" first="Jing" last="Li">Jing Li</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Li, Shufen" sort="Li, Shufen" uniqKey="Li S" first="Shufen" last="Li">Shufen Li</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Huang, Jinfeng" sort="Huang, Jinfeng" uniqKey="Huang J" first="Jinfeng" last="Huang">Jinfeng Huang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ning, Ye" sort="Ning, Ye" uniqKey="Ning Y" first="Ye" last="Ning">Ye Ning</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gao, Hong" sort="Gao, Hong" uniqKey="Gao H" first="Hong" last="Gao">Hong Gao</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qin, Chuan" sort="Qin, Chuan" uniqKey="Qin C" first="Chuan" last="Qin">Chuan Qin</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">The Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dong, Xiaoping" sort="Dong, Xiaoping" uniqKey="Dong X" first="Xiaoping" last="Dong">Xiaoping Dong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Institute for Virology, Chinese Center for Disease Control and Prevention, Beijing 100052, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute for Virology, Chinese Center for Disease Control and Prevention, Beijing 100052</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wei, Jianguo" sort="Wei, Jianguo" uniqKey="Wei J" first="Jianguo" last="Wei">Jianguo Wei</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dong, Guanmu" sort="Dong, Guanmu" uniqKey="Dong G" first="Guanmu" last="Dong">Guanmu Dong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff4">National Institute for the Control of Pharmaceutical and Biological Products, Tiantan Xili 2, Beijing 100050, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Institute for the Control of Pharmaceutical and Biological Products, Tiantan Xili 2, Beijing 100050</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yin, Weidong" sort="Yin, Weidong" uniqKey="Yin W" first="Weidong" last="Yin">Weidong Yin</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<idno type="eISSN">1873-2518</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>A reference antiserum for SARS is in urgent need in the development of SARS vaccine and other serological test of SARS research. Convalescent serum was collected from clinical confirmed patient. ELISA, Western-blotting and neutralization assay detected specific antibody against SARS coronavirus. This antiserum was prepared as in-house reference antiserum, freeze-dried and sealed in ampoules. The potency of this reference antiserum is defined to be 52.7 U after extensive calibration. Further, collaborative studies for the evaluation of this serum are needed in order to satisfy the requirements for international reference antiserum.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="May, J C" uniqKey="May J">J.C. May</name>
</author>
<author>
<name sortKey="Grim, E" uniqKey="Grim E">E. Grim</name>
</author>
<author>
<name sortKey="Wheeler, R M" uniqKey="Wheeler R">R.M. Wheeler</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Vaccine</journal-id>
<journal-id journal-id-type="iso-abbrev">Vaccine</journal-id>
<journal-title-group>
<journal-title>Vaccine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0264-410X</issn>
<issn pub-type="epub">1873-2518</issn>
<publisher>
<publisher-name>Elsevier Ltd.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">16269206</article-id>
<article-id pub-id-type="pmc">7115399</article-id>
<article-id pub-id-type="publisher-id">S0264-410X(05)00301-4</article-id>
<article-id pub-id-type="doi">10.1016/j.vaccine.2004.12.032</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Preparation and characterization of SARS in-house reference antiserum</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jiansan</given-names>
</name>
<email>ZhangJS@Sinovac.com</email>
<xref rid="aff1" ref-type="aff">a</xref>
<xref rid="cor1" ref-type="corresp"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yuxuan</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Liangxiang</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Qiang</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Zhenshan</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiaomei</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Jiangting</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gong</surname>
<given-names>Xuejie</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Lifei</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yufen</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jing</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Shufen</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Jinfeng</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ning</surname>
<given-names>Ye</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Hong</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Chuan</given-names>
</name>
<xref rid="aff2" ref-type="aff">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Xiaoping</given-names>
</name>
<xref rid="aff3" ref-type="aff">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Jianguo</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Guanmu</given-names>
</name>
<xref rid="aff4" ref-type="aff">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yin</surname>
<given-names>Weidong</given-names>
</name>
<xref rid="aff1" ref-type="aff">a</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>a</label>
Sinovac Biotech Co. Ltd., No. 39, Shangdi Xi Road, Haidian District, Beijing 100085, PR China</aff>
<aff id="aff2">
<label>b</label>
The Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, PR China</aff>
<aff id="aff3">
<label>c</label>
Institute for Virology, Chinese Center for Disease Control and Prevention, Beijing 100052, PR China</aff>
<aff id="aff4">
<label>d</label>
National Institute for the Control of Pharmaceutical and Biological Products, Tiantan Xili 2, Beijing 100050, PR China</aff>
<author-notes>
<corresp id="cor1">
<label></label>
Corresponding author. Fax: +86 10 62966910.
<email>ZhangJS@Sinovac.com</email>
</corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>16</day>
<month>3</month>
<year>2005</year>
</pub-date>
<pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="ppub">
<day>1</day>
<month>12</month>
<year>2005</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>3</month>
<year>2005</year>
</pub-date>
<volume>23</volume>
<issue>48</issue>
<fpage>5666</fpage>
<lpage>5669</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>2</month>
<year>2004</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>9</month>
<year>2004</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>12</month>
<year>2004</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2005 Elsevier Ltd. All rights reserved.</copyright-statement>
<copyright-year>2005</copyright-year>
<copyright-holder>Elsevier Ltd</copyright-holder>
<license>
<license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
</license>
</permissions>
<abstract>
<p>A reference antiserum for SARS is in urgent need in the development of SARS vaccine and other serological test of SARS research. Convalescent serum was collected from clinical confirmed patient. ELISA, Western-blotting and neutralization assay detected specific antibody against SARS coronavirus. This antiserum was prepared as in-house reference antiserum, freeze-dried and sealed in ampoules. The potency of this reference antiserum is defined to be 52.7 U after extensive calibration. Further, collaborative studies for the evaluation of this serum are needed in order to satisfy the requirements for international reference antiserum.</p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>SARS</kwd>
<kwd>Reference antiserum</kwd>
<kwd>Neutralization antibody potency</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
<settlement>
<li>Pékin</li>
</settlement>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Zhang, Jiansan" sort="Zhang, Jiansan" uniqKey="Zhang J" first="Jiansan" last="Zhang">Jiansan Zhang</name>
</noRegion>
<name sortKey="Chen, Jiangting" sort="Chen, Jiangting" uniqKey="Chen J" first="Jiangting" last="Chen">Jiangting Chen</name>
<name sortKey="Dong, Guanmu" sort="Dong, Guanmu" uniqKey="Dong G" first="Guanmu" last="Dong">Guanmu Dong</name>
<name sortKey="Dong, Xiaoping" sort="Dong, Xiaoping" uniqKey="Dong X" first="Xiaoping" last="Dong">Xiaoping Dong</name>
<name sortKey="Gao, Hong" sort="Gao, Hong" uniqKey="Gao H" first="Hong" last="Gao">Hong Gao</name>
<name sortKey="Gao, Qiang" sort="Gao, Qiang" uniqKey="Gao Q" first="Qiang" last="Gao">Qiang Gao</name>
<name sortKey="Gong, Xuejie" sort="Gong, Xuejie" uniqKey="Gong X" first="Xuejie" last="Gong">Xuejie Gong</name>
<name sortKey="Hu, Liangxiang" sort="Hu, Liangxiang" uniqKey="Hu L" first="Liangxiang" last="Hu">Liangxiang Hu</name>
<name sortKey="Huang, Jinfeng" sort="Huang, Jinfeng" uniqKey="Huang J" first="Jinfeng" last="Huang">Jinfeng Huang</name>
<name sortKey="Li, Jing" sort="Li, Jing" uniqKey="Li J" first="Jing" last="Li">Jing Li</name>
<name sortKey="Li, Shufen" sort="Li, Shufen" uniqKey="Li S" first="Shufen" last="Li">Shufen Li</name>
<name sortKey="Liu, Yufen" sort="Liu, Yufen" uniqKey="Liu Y" first="Yufen" last="Liu">Yufen Liu</name>
<name sortKey="Liu, Yuxuan" sort="Liu, Yuxuan" uniqKey="Liu Y" first="Yuxuan" last="Liu">Yuxuan Liu</name>
<name sortKey="Ning, Ye" sort="Ning, Ye" uniqKey="Ning Y" first="Ye" last="Ning">Ye Ning</name>
<name sortKey="Qin, Chuan" sort="Qin, Chuan" uniqKey="Qin C" first="Chuan" last="Qin">Chuan Qin</name>
<name sortKey="Song, Lifei" sort="Song, Lifei" uniqKey="Song L" first="Lifei" last="Song">Lifei Song</name>
<name sortKey="Wei, Jianguo" sort="Wei, Jianguo" uniqKey="Wei J" first="Jianguo" last="Wei">Jianguo Wei</name>
<name sortKey="Yin, Weidong" sort="Yin, Weidong" uniqKey="Yin W" first="Weidong" last="Yin">Weidong Yin</name>
<name sortKey="Zhang, Xiaomei" sort="Zhang, Xiaomei" uniqKey="Zhang X" first="Xiaomei" last="Zhang">Xiaomei Zhang</name>
<name sortKey="Zhang, Zhenshan" sort="Zhang, Zhenshan" uniqKey="Zhang Z" first="Zhenshan" last="Zhang">Zhenshan Zhang</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001277 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 001277 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    RBID
   |clé=     PMC:7115399
   |texte=   Preparation and characterization of SARS in-house reference antiserum
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i   -Sk "pubmed:16269206" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021